Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatic artery chemoembolization.

Kevin L Sullivan1

  • 1Department of Radiology, Division of Cardiovascular and Interventional Radiology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.

Seminars in Oncology
|April 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases.

Journal of vascular and interventional radiology : JVIR·2015
Same author

Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study.

AJR. American journal of roentgenology·2011
Same author

Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience.

AJR. American journal of roentgenology·2011
Same author

Ventilator-associated pneumonia and oral care: a successful quality improvement project.

American journal of infection control·2009
Same author

High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanoma.

Radiology·2009
Same author

Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2008
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
Same journal

Stoma-free precision sphincter-preserving surgery with J-pouch for metastatic low rectal neuroendocrine tumor.

Seminars in oncology·2026
See all related articles

Chemoembolization delivers high drug concentrations to the liver, showing survival benefits for hepatocellular carcinoma. Its efficacy for liver metastases varies by cancer type, with ongoing trials for colorectal cancer.

Area of Science:

  • Interventional Radiology
  • Hepatobiliary Oncology
  • Medical Oncology

Background:

  • Chemoembolization involves delivering high concentrations of therapeutic agents directly to the liver.
  • Significant experience exists for hepatocellular carcinoma (HCC) treatment.
  • Less data is available for chemoembolization in hepatic metastases.

Purpose of the Study:

  • To review the current applications and efficacy of chemoembolization for liver tumors.
  • To assess the benefits of chemoembolization in hepatocellular carcinoma versus conservative therapy.
  • To evaluate the effectiveness of chemoembolization for various types of hepatic metastases.

Main Methods:

  • Review of existing clinical experience and literature.
  • Analysis of outcomes in patients with hepatocellular carcinoma.

Related Experiment Videos

  • Assessment of patient responses in hepatic metastases from carcinoid, pancreatic islet cell tumors, and sarcoma.
  • Consideration of ongoing multicenter trials for colorectal cancer metastases.

    • Main Results:

    • Chemoembolization is a safe procedure for hepatocellular carcinoma, offering a survival advantage over conservative therapy.
    • Patients with carcinoid, pancreatic islet cell tumor, and sarcoma metastatic to the liver show benefit from chemoembolization.
    • The efficacy of chemoembolization for colorectal cancer metastatic to the liver is not well established.

    Conclusions:

    • Chemoembolization is a valuable and safe treatment for hepatocellular carcinoma.
    • Chemoembolization shows promise for specific types of liver metastases.
    • Further research, including multicenter trials, is needed to clarify the role of chemoembolization in other metastatic liver diseases, particularly colorectal cancer.